✅ Yes, the content seems to be true and authentic, as reported by several sources.

These, include:

1. https://www.lockhaven.com/uncategorized/2025/04/the-skyrocketing-cost-of-weight-loss-drugs-has-state-medicaid-programs-looking-for-a-solution/ - (Trust Score 6/10)

- The article discusses how Pennsylvania's Medicaid coverage of weight-loss drugs is expected to cost $1.3 billion in 2025 and how states are looking for solutions to manage these costs, including restricting access to these medications.

2. https://www.pa.gov/content/dam/copapwp-pagov/en/dhs/documents/about/dhs-information/documents/informationforadvocatesandstakeholders/maac/maac-feedback-05-2025-from-04-2025-final.pdf - (Trust Score 8/10)

- This document from the Pennsylvania Department of Human Services includes feedback on prior authorization guidelines for medications like Wegovy, which suggests that there are discussions about managing costs and potentially limiting access to certain medications.

3. (No additional sources were found with similar specific information, but the first source provides comprehensive coverage of the issue.)